Revolutionary radio frequency technology to manage pain.
Innovation Backed by Evidence
Our proprietary neuromodulation technology focuses Rf energy with millimeter precision to influence pain pathways and promote natural healing responses.
Backed by early preclinical data demonstrating significant pain reduction.
Guided by experts in biomedical engineering and pain medicine.
Built on a scalable, FDA-aligned platform for multiple pain indications.
Learn More about the Technology
Innovation Backed by Business Know-How
With decades of focused radio frequency experience, medical device experience, and multiple exits our team is serious about revolutionizing how pain is treated. We bring a medtech solution that belongs in the next generation of clinics.
Meet the Team
Innovation Backed by Grant Support
Hypersound Medical has secured a total of $554,000 in early-stage funding, demonstrating strong validation from both public and private partners. This combined support underscores confidence in Hypersound’s breakthrough approach to non-invasive pain therapy and positions the company for its next phase of clinical and commercial growth.
Innovation Backed by Academic Recognition
Our cutting-edge neuromodulation technology, which is on the path to FDA clearance, has been proven to be safe in human studies and can be applied in pain management clinics and physical therapy environments. Read the article.
Market Ready for Disruption
Why Invest in the Hypersound Device?
Our mission is simple: empower people to live pain-free through safe, targeted innovation.
Non-invasive and non-pharmacologic
Personalized therapy settings
Portable and easy to administer
Designed for both clinical and home use
Safe and effective
Investor FAQs
We have attempted to answer a few of the questions we often receive from prospective investors in regards to our revolutionary hypersound technology for relieving pain without drugs, needles, or surgical interventions.
What is Hypersound Medical’s mission?
Our mission is to transform pain management through precision ultrasound by delivering non-invasive, drug-free, and affordable relief to help people live pain-free without dependency or risk.
What makes Hypersound’s technology unique?
We’re the first to use focused radiofrequency for precision nerve stimulation. We achieve targeted pain relief without surgery, implants, or pharmaceuticals. This bridges the gap between ineffective TENS units and costly invasive procedures.
What stage is Hypersound currently in?
We’re in the advanced prototype and pre-clinical validation phase, preparing for initial clinical studies and strategic partnerships that will accelerate commercialization.
How much funding has Hypersound secured to date?
To date, we’ve secured $554,000 through a combination of grants, founder contributions, and private equity investment, including NSF SBIR funding and Arizona Commerce Authority support.
What are the next major milestones?
Upcoming milestones include:
- Completion of pre-clinical trials
- Regulatory pathway validation (FDA 510(k) planning)
- First-in-human studies
- Strategic partnerships and Series A fundraising
What is the size of the addressable market?
Does Hypersound have intellectual property protection?
Yes.
- All IP 100% wholly owned by Hypersound Medical Inc. without limit or restriction.
- All consultants and employees sign IP assignment agreements.
- ASU collaboration completed with no additional IP claims asserted.
The core technology based on multi-antenna electrostriction mechanism has no direct competitors in the market. Patent covers device configuration and therapeutic method, creating strong barriers to entry. The combination of precision nerve stimulation without surgery represents a first-in-class innovation that is difficult to design around without infringing on protected claims.
What type of investors is Hypersound seeking?
We’re seeking strategic investors and early-stage venture partners who share our vision of redefining pain management through innovation, scalability, and social impact.
How can I get in touch regarding investment opportunities?
Interested investors can contact us directly by email at info@hypersoundmedical.com to request a pitch deck or schedule a discussion.